Immix Biopharma (IMMX) Earnings Date, Estimates & Call Transcripts $2.95 +0.19 (+6.88%) Closing price 04:00 PM EasternExtended Trading$2.92 -0.03 (-0.85%) As of 05:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Immix Biopharma Earnings Summary Immix Biopharma issued Q4 2024 earnings on March 24, 2025, reporting an EPS of -$0.16, which beat the consensus estimate of -$0.25 by $0.09. With a trailing EPS of -$0.70, Immix Biopharma's earnings are expected to grow next year, from ($0.87) to ($0.85) per share. Upcoming Earnings DateAug. 11Before Market OpensEstimatedConsensus EPS (Mar. 24) -$0.25 Actual EPS (Mar. 24) -$0.16 Beat By $0.09 Q4 2024 Earnings ResourcesQ4 2024 Earnings Report Annual Report (10-K)IMMX Upcoming EarningsImmix Biopharma's Q1 2025 earnings is scheduled for Monday, August 11, 2025Powered by Get Immix Biopharma Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Immix Biopharma and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataIMMX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Immix Biopharma Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.23-$0.23-$0.23Q2 20251-$0.21-$0.21-$0.21Q3 20251-$0.16-$0.16-$0.16Q4 20251-$0.15-$0.15-$0.15 FY 2025 4 -$0.75 -$0.75 -$0.75 Q1 20261-$0.14-$0.14-$0.14Q2 20261-$0.15-$0.15-$0.15Q3 20261-$0.17-$0.17-$0.17Q4 20261-$0.19-$0.19-$0.19 Immix Biopharma Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/11/2025(Estimated)--------3/24/2025Q4 2024-$0.25-$0.16+$0.09-$0.16--11/12/2024--$0.16-$0.24 -$0.08-$0.24--8/12/2024--$0.21-$0.15+$0.06-$0.15--5/9/2024Q1 2024-$0.23-$0.22+$0.01-$0.22--3/29/2024Q4 2023--$0.24--$0.24--11/9/2023Q3 2023-$0.23-$0.23--$0.23--8/11/2023Q2 2023-$0.17-$0.24 -$0.07-$0.24-- Immix Biopharma Earnings - Frequently Asked Questions When is Immix Biopharma's earnings date? Immix Biopharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 11th, 2025 based off last year's report dates. Learn more on IMMX's earnings history. Did Immix Biopharma beat their earnings estimates last quarter? In the previous quarter, Immix Biopharma (NASDAQ:IMMX) reported ($0.16) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.25) by $0.09. Learn more on analysts' earnings estimate vs. IMMX's actual earnings. How much profit does Immix Biopharma generate each year? Immix Biopharma (NASDAQ:IMMX) has a recorded net income of -$21.61 million. IMMX has generated -$0.70 earnings per share over the last four quarters. What is Immix Biopharma's EPS forecast for next year? Immix Biopharma's earnings are expected to grow from ($0.87) per share to ($0.85) per share in the next year. More Earnings Resources from MarketBeat Related Companies ABEO Earnings Date INBX Earnings Date ADCT Earnings Date CADL Earnings Date SGMT Earnings Date NGNE Earnings Date AARD Earnings Date FHTX Earnings Date PVLA Earnings Date TRDA Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles 3 Analysts Set $600 Target Ahead of Microsoft EarningsTesla: 2 Plays Ahead of Next Week's Earnings ReportFastenal Surges After Earnings Beat, Tariff Risks Loom3 Catalysts Converge on Intel Ahead of a Critical Earnings ReportSmith & Wesson Stock Falls on Earnings Miss, Tariff WoesWhat to Expect From the Q2 Earnings Reporting CycleBroadcom Slides on Solid Earnings, AI Outlook Still Strong This page (NASDAQ:IMMX) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersRevolutionary AI Tech Targets Early Diabetic Blindness Detection FDA Trial UnderwayTiny Stock, Massive Potential— this company’s AI platform is a game changer for healthcare!Interactive Offers | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredBank of America Says Gold Could Hit $4,000. Here How to Get Paid“I’ve always hated gold. It doesn’t pay dividends… it just sits there.” That’s what one income strategist b...Investors Alley | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immix Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Immix Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IMMX Stock Alerts